feed,title,long_url,short_url
Benzinga,"Comparing With Pfizer's Vaccine, Icosavax RSV Candidate 'Could Establish Differentiation,' Analyst Says",https://benzinga.com/analyst-ratings/analyst-color/22/12/30079143/comparing-with-pfizers-vaccine-icosavax-rsv-candidate-could-establish-differentiati,https://da.gd/wP4SK
Benzinga,"Charter's Network Upgrade Impressive, While Capex Likely To Hurt FCF & Buybacks, Analysts Say",https://benzinga.com/analyst-ratings/analyst-color/22/12/30079189/charters-network-upgrade-impressive-while-capex-likely-to-hurt-fcf-buybacks-analyst,https://da.gd/HWMViJ
